Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
-
Authors :
Monod EC; Department of Biology, Wilfrid Laurier University, Waterloo, Canada; Department of Biology, University of Waterloo, Waterloo, Canada.
Subjects: Pituitary Adenylate Cyclase-Activating Polypeptide*/Pituitary Adenylate Cyclase-Activating Polypeptide*/Pituitary Adenylate Cyclase-Activating Polypeptide*/pharmacology ; Adjuvants, Immunologic*/Adjuvants, Immunologic*/Adjuvants, Immunologic*/pharmacology; Animals
-
Source:
Fish & shellfish immunology [Fish Shellfish Immunol] 2024 Mar; Vol. 146, pp. 109388. Date of Electronic Publication: 2024 Jan 18.Publisher: Academic Press Country of Publication: England NLM ID: 9505220 Publication Model: Print-Electronic Cited Medium: Internet ISSN:
Record details
-
Authors :
Tóth D; Department of Forensic Medicine, University of Pécs Medical School, Szigeti út 12, H-7624 Pécs, Hungary.; Simon G
Subjects: Pituitary Adenylate Cyclase-Activating Polypeptide*/Pituitary Adenylate Cyclase-Activating Polypeptide*/Pituitary Adenylate Cyclase-Activating Polypeptide*/metabolism ; Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I*/Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I*/Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I*/genetics ; Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I*/Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I*/Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I*/metabolism
-
Source:
International journal of molecular sciences [Int J Mol Sci] 2023 Oct 11; Vol. 24 (20). Date of Electronic Publication: 2023 Oct 11.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067
Record details
-
Authors :
Langer G; Bayer AG, Research & Development, Pharmaceuticals, Berlin, Germany (G.L., U.B., J.M., B.l.R., S.B.); Bayer AG, Research & Development, Pharmaceuticals, Wuppertal, Germany (C.O., A.L.-B.)
Subjects: Pituitary Adenylate Cyclase-Activating Polypeptide*/Pituitary Adenylate Cyclase-Activating Polypeptide*/Pituitary Adenylate Cyclase-Activating Polypeptide*/pharmacology ; Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I*/Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I*/Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I*/chemistry; Humans
-
Source:
Molecular pharmacology [Mol Pharmacol] 2023 Sep; Vol. 104 (3), pp. 105-114. Date of Electronic Publication: 2023 Jun 22.Publisher: American Society for Pharmacology and Experimental Therapeutics Country of Publication: United States NLM ID: 0035623 Publication Model:
Record details